KATHERINE HORNER: Open Payments
NPI 1285789420 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,075 in 51 payments from 19 companies in 2025. Trend: 2023 $503 · 2024 $684 · 2025 $1,075
Food & beverage: $1,075
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $229 |
| Amgen Inc. | 8 | $211 |
| Regeneron Healthcare Solutions, Inc. | 2 | $140 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Medtronic, Inc. | 1 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| Novo Nordisk Inc | 3 | $45 |
| HARMONY BIOSCIENCES LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| PFIZER INC. | 2 | $30 |
Products named: EVKEEZA, REPATHA, VRAYLAR, QULIPTA, EVENITY, SYMPLICITY G3, XIFAXAN, REXULTI.
Industry payments across NE — which companies pay providers there.
